Worldwide, cryptococcal meningitis kills up to 180,000 persons annually and is the most common cause of nonviral meningitis in the United States. Besides patients with immunosuppression due to human ...

Ultimately, the goal is to find ways to stop deadly disease caused by Cryptococcus neoformans from developing in humans and animals. But until that time, finding new and better ways to treat already ...

A lab has completed a six-year study to examine the virulence of 38 clinical isolates from various strains of Cryptococcus. Ultimately, the goal is to find ways to stop deadly disease caused by ...

Introduction Cryptococcal meningitis (CM) is an infection of the central nervous system that accounts for approximately 19% ...

Dar es Salaam / Lilongwe / Geneva — 15 April 2025 — A new, easier-to-administer and patient-friendly sustained-release formulation of flucytosine, a medicine used to treat cryptococcal meningitis, has ...

A group of international mycology experts led by Professor Dr. Oliver A. Cornely at the University of Cologne has jointly drafted a guideline for the diagnosis and treatment of cryptococcosis, which ...

Please provide your email address to receive an email when new articles are posted on . A large study conducted in five African countries identified an easier and less toxic treatment for ...

A group of international mycology experts led by Professor Dr Oliver A. Cornely at the University of Cologne has jointly drafted a guideline for the diagnosis and treatment of cryptococcosis, which ...

Diffuse large B-cell lymphoma in HHV8+ multicentric castleman disease: A national analysis of demographic features.

Treatment of cryptococcal meningitis typically includes 1 week of intravenous therapy with amphotericin B deoxycholate. However, this treatment carries a substantial risk of toxic effects, and the ...